DCF — GARNET HEALTH MEDICAL CENTER - CATSK
Enterprise Value: $-72.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-72.2M
Enterprise Value
$-24.2M
PV of Cash Flows
$-48.1M
PV of Terminal Value
$-77.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $84.1M | $-3.8M | -5.0% | $-7.3M | $-6.7M |
| Year 2 | $86.6M | $-3.0M | -4.0% | $-6.7M | $-5.5M |
| Year 3 | $89.2M | $-2.2M | -3.0% | $-6.0M | $-4.5M |
| Year 4 | $91.9M | $-1.8M | -2.0% | $-5.7M | $-3.9M |
| Year 5 | $94.7M | $-1.7M | -2.0% | $-5.7M | $-3.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-72.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$81.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000004286485523
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5